Abacavir lamivudine labels and packages

Revision as of 01:51, 10 January 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Abacavir lamivudine}} {{CMG}}; {{AE}} {{SS}} ==Labels And Packages== {| |- |thumb|850px|left |- |}<ref name="dailymed.nlm.nih.g...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Abacavir lamivudine
EPZICOM ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

File:Abacavir lamivudine 8.jpg

[1]

References

  1. "EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]". Retrieved 10 January 2014.

Adapted from the FDA Package Insert.